COMMUNIQUÉS West-GlobeNewswire

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

19/02/2018 - 13:01

FIT Biotech Oy Company release February 19, 2018 at 2:00 PM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on December 22, 2017 [...]

Novo Nordisk A/S - Share repurchase programme

19/02/2018 - 12:12

Bagsværd, Denmark, 19 February 2018 - On 5 February 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April [...]

Notice of Annual General Meeting

19/02/2018 - 09:04

Valby, Denmark, 2018-02-19 09:04 CET (GLOBE NEWSWIRE) -- Valby, Denmark, 19 February 2018 – Notice is hereby given of the annual general meeting of H. Lundbeck A/S to be held on: Tuesday, 20 March 2018 at 10:00 am The [...]

Oasmia Pharmaceutical’s Docecal program achieves significant development milestone

19/02/2018 - 08:30

Oasmia Pharmaceutical AB announces that all patients have been treated in the two ongoing studies with Docecal in metastatic breast cancer. Uppsala, Sweden, February 19, 2018 – Oasmia Pharmaceutical AB (NASDAQ: OASM), a [...]

Bone Therapeutics SA completes patient recruitment for Phase IIA Spinal Fusion study with ALLOB®

19/02/2018 - 07:01

Press release Bone Therapeutics completes patient recruitment for Phase IIA Spinal Fusion study with ALLOB ® Efficacy and safety results expected in mid-2019 Promising interim efficacy and safety data already reported [...]

Bone Therapeutics annonce le recrutement du dernier patient de son étude de Phase IIA dans la fusion vertébrale avec ALLOB®

19/02/2018 - 07:01

Communiqué de presse Bone Therapeutics annonce le recrutement du dernier patient de son étude de Phase IIA dans la fusion vertébrale avec ALLOB ® Résultats d'efficacité et de sécurité attendus mi-2019 Données [...]

MediciNova Announces Upcoming Presentation of the SPRINT-MS Phase 2b Trial of MN-166 (ibudilast) in Progressive MS at the American Academy of Neurology (AAN) 70th Annual Meeting in Los Angeles, California

19/02/2018 - 00:00

LA JOLLA, Calif., Feb. 18, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV ) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875 [...]

New Data in Pediatric Patients with Axillary Hyperhidrosis Presented During Late-Breaking Research Forum at the 76th Annual Meeting of the American Academy of Dermatology

18/02/2018 - 00:30

SAN DIEGO, Feb. 17, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM ), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the [...]

AnaptysBio Presents Updated Data from ANB020 Phase 2a Atopic Dermatitis Trial at AAD Annual Meeting

17/02/2018 - 23:00

SAN DIEGO, Feb. 17, 2018 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB ), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation [...]

TLC Files Registration Statement for Proposed Initial Public Offering

17/02/2018 - 10:06

TAIPEI, Taiwan, Feb. 17, 2018 (GLOBE NEWSWIRE) -- Taiwan Liposome Company, Ltd. (4152.TWO) (TLC), a clinical-stage specialty pharmaceutical company dedicated to the development and commercialization of novel [...]

Galapagos and MorphoSys present results from a Phase 1 study with MOR106 in atopic dermatitis as late-breaking abstract at the American Academy of Dermatology (AAD) meeting in San Diego

17/02/2018 - 10:01

MOR106 was generally well tolerated in atopic dermatitis (AD) patients 83% of patients (5 out of 6) at the highest dose reached at least 50% improvement per the atopic dermatitis area and severity index (EASI-50) at [...]

ChromaDex Chairman Stephen Allen Will Retire from Board of Directors

16/02/2018 - 22:30

IRVINE, Calif., Feb. 16, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corporation (NASDAQ: CDXC ), a science-based, integrated nutraceutical company devoted to pioneering technologies that improve the way people age is announcing [...]

OncBioMune Provides Update on Market Activity

16/02/2018 - 22:23

BATON ROUGE, La., Feb. 16, 2018 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary [...]

Novartis new data show Cosentyx® improved quality of life over 5 years in two thirds of patients with moderate to severe plaque psoriasis

16/02/2018 - 22:06

Two thirds of patients on Cosentyx ® (secukinumab) reported no impact of skin disease on their quality of life over 5 years, SCULPTURE study shows[1] Findings show absolute PASI <=1/<=2/<=3 responses were [...]

Pernix Therapeutics Announces Launch of Authorized Generic Version of Treximet® by Company’s Subsidiary, Macoven Pharmaceuticals

16/02/2018 - 22:01

MORRISTOWN, N.J., Feb. 16, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX ), a specialty pharmaceutical company, today announced the launch of an authorized generic version of Treximet® ( [...]

HydRx Farms Ltd. (d/b/a Scientus Pharma Inc.) Announces Completion of its $15.8 Million Private Placement Offering of Common Shares

16/02/2018 - 20:16

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. TORONTO, Feb. 16, 2018 (GLOBE NEWSWIRE) -- [...]

Avinger Announces Closing of $18 Million Underwritten Public Offering

16/02/2018 - 19:30

REDWOOD CITY, Calif., Feb. 16, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ: AVGR ), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced the closing of an underwritten [...]

Medifirst Solutions Announces a Business Update

16/02/2018 - 19:22

FREEHOLD, NJ, Feb. 16, 2018 (GLOBE NEWSWIRE) -- MEDIFIRST SOLUTIONS, INC. (OTC: MFST) (the “Company” or “Medifirst”), a provider of innovative laser technology with its FDA 510(k) cleared Infrared Time Machine TTML- [...]

The Delta Companies Recognized with Best of Staffing® Awards 2018

16/02/2018 - 19:00

DALLAS, Feb. 16, 2018 (GLOBE NEWSWIRE) -- The Delta Companies (TDC) , a leading staffing firm for healthcare professionals nationwide, has announced it has been recognized with several Inavero Best of Staffing® Awards [...]